GATA3 and cancer: Ours is the second largest study that has analyzed the prognostic impact of GATA3 IHC, and it is worth noting that results from the two largest studies confirmed an independent association with the prognosis, even in stratified analyses by cancer subtype, that smaller studies could not detect.